Marketing-authorisation holder · United States
Alvotech USA Inc.
8 medicines in 1 country, as authorisation holder.
Group structure
Part of
AlvotechPharmaceutical groupOther companies in the group
Iceland1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
8 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Selarsdi130mg/26ml (5mg/ml) · Injection | Ustekinumab | United States | Marketed | 2024 |
| SELARSDI45mg/0.5ml | 90mg/ml · Injectable | Ustekinumab | United States | Marketed | 2024 |
| Selarsdi45mg/0.5ml · Injection | Ustekinumab | United States | Marketed | 2025 |
| Simlandi40mg/0.4ml · Injection | Adalimumab | United States | Marketed | 2024 |
| Simlandi80mg/0.8ml · Injection | Adalimumab | United States | Marketed | 2024 |
| SIMLANDI40mg/0.4ml · Injectable | Adalimumab | United States | Marketed | 2024 |
| Simlandi80mg/0.8ml · Injection | Adalimumab | United States | Marketed | 2025 |
| Simlandi20mg/0.2ml · Injection | Adalimumab | United States | Marketed | 2024 |